MAYER ARIE purchased 48.9% of their position (8.81K shares) of ORAMED PHARMACEUTICALS INC. on the open market
Open‑market purchase worth $19.5K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 4/4/2023ACC: 0001209191-23-022815
+8.81K
Net shares
Net buyer
$19.5K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
8.81K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5.01K
Price / share
$2.22
Trade value
$11.12K
% of position
27.8%
4/3/2023
18K→23.01K
Common Stock
Direct
Shares
+3.80K
Price / share
$2.21
Trade value
$8.40K
% of position
16.5%
4/4/2023
23.01K→26.81K
Total
Net shares
+8.81K
Net value
$19.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/3/2023 | P · Purchase | +5.01K | $2.22 | $11.12K | 27.8% | 18K | 23.01K |
| Common Stock Direct | 4/4/2023 | P · Purchase | +3.80K | $2.21 | $8.40K | 16.5% | 23.01K | 26.81K |
| Total | +8.81K | $19.52K | ||||||
Derivative Transactions0
No derivative transactions reported